4 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology ... #Oncology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Treatment Algorithm ... therapy - Second VTE ... #Treatment #Algorithm ... #management #hematology ... #anticoagulation
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
Immunohistochemical studies (to differentiate ... Hodgkin Lymphoma Treatment ... #classification ... #hematology #oncology ... #management